SCHEMBL1344807

SCHEMBL1344807

CCC(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.36
CTSS P25774 2/20 0.36
DGAT1 O75907 1/20 0.34
CA1 P00915 3/20 0.34
CA2 P00918 2/20 0.34
CA7 P43166 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 1/20 0.34
NOS1 P29475 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTT P42858 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
NOS3 P29474 1/20 0.33
NOS2 P35228 1/20 0.33
SYK P43405 1/20 0.33
CA12 O43570 2/20 0.32
CA14 Q9ULX7 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4477961 0.91 CA1 (0.42) CTSKCTSSDGAT1CA1CA2
SCHEMBL2439297 0.91 HTT (0.40) KMT2ALMNACYP1A2CYP2C9CYP2C19
SCHEMBL28710632 0.91 KMT2A (0.39) CTSKCTSSDGAT1CA1CA2
SCHEMBL1344808 0.91 KMT2A (0.39) CTSKCTSSDGAT1CA1CA2
SCHEMBL27382689 0.89 DGAT1 (0.33) CTSKCTSSDGAT1CA1CA2
SCHEMBL27937233 0.89 DGAT1 (0.33) CTSKCTSSDGAT1CA1CA2
SCHEMBL28173071 0.89 CTSS (0.33) CTSKCTSSDGAT1CA1CA2
SCHEMBL19206295 0.87 KMT2A (0.34) CTSKCTSSDGAT1CA1CA2
Methylamine SCHEMBL28534491 0.87 KMT2A (0.37) CTSKCTSSCA2KMT2ALMNA
SCHEMBL27969605 0.87 CTSK (0.33) CTSKCTSSDGAT1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114805647-A Catalyst composition for olefin polymerization and application thereof 北京肯佰恩科技发展有限公司 2022-07-29 CN claimed
CN-113273075-A Electrostatic machine system and method of operation C-莫蒂夫技术公司 2021-08-17 CN claimed
EP-3053935-B1 CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION AND APPLICATION OF SAME CHINA PETROLEUM & CHEM CORP (CN) 2019-05-08 EP claimed
US-9822196-B2 Catalyst composition for olefin polymerization and application of same CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2017-11-21 US claimed
US-20160244538-A1 CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION AND APPLICATION OF SAME BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2016-08-25 US claimed
EP-3053935-A1 CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION AND APPLICATION OF SAME China Petroleum & Chemical Corporation (CN) 2016-08-10 EP claimed
US-11993617-B2 Organic luminescent material having an ancillary ligand with a partially fluorine-substituted substituent Beijing Summer Sprout Technology Co., Ltd. (CN) 2024-05-28 US disclosed
CN-116082936-B Blocked polyisocyanate composition and method for producing same, resin composition, resin film and method for producing same, and laminate 旭化成株式会社 2024-04-05 CN disclosed
CN-114805647-B Catalyst composition for olefin polymerization and application thereof 北京肯佰恩科技发展有限公司 2024-03-29 CN disclosed
CN-117645828-A Coating composition for substrate, multilayer coating film laminate, and method for forming multilayer coating film laminate 旭化成株式会社 2024-03-05 CN disclosed
EP-3694503-B1 NOVEL SUBSTITUTED CYCLOBUTYLPYRIDINE AND CYCLOBUTYLPYRIMIDINE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-08-02 EP disclosed
CN-112679548-B Organic light-emitting materials with ancillary ligands having partially fluoro substituted substituents 北京夏禾科技有限公司 2023-07-28 CN disclosed
CN-111032603-B Iron-catalyzed transesterification hydrogenation of esters to alcohols 伊士曼化工公司 2023-07-25 CN disclosed
WO-2002024703-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AKZO NOBEL N.V. (NL) 2002-03-28 WO disclosed
EP-1189612-A1 VLA-4 INHIBITOR COMPOUNDS Daiichi Pharmaceutical Co., Ltd. (JP) 2002-03-27 EP disclosed
WO-2001000206-A1 VLA-4 INHIBITOR COMPOUNDS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-01-04 WO disclosed
EP-0367131-B1 Light-sensitive composition BASF AG (DE) 1995-02-22 EP disclosed
US-5035979-A Radiation-sensitive mixture BASF AKTIENGESELLSCHAFT (DE) 1991-07-30 US disclosed
EP-0367131-A2 Light-sensitive composition BASF Aktiengesellschaft (DE) 1990-05-09 EP disclosed
US-3932121-A Process for the dyeing of modified polyester fibers HODOGAYA KAGAKU KOGYO KABUSHIKI KAISHA (JA) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11993617-B2 Organic luminescent material having an ancillary ligand with a partially fluorine-substituted substituent KCNK10, KCNQ1, KCNK2 CTSK 507/4885CTSS 2896/4885DGAT1 957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.